To explore the contribution of DSBs in mediating antitumor cytotoxicity of AF analogs, occurrence of DSBs in human colon cancer DLD1 isogenic cell lines (WT and BRCA2 KO) in response to LP-184 treatment was evaluated using the STRIDE technology (29). This evidence concerns the gene BRCA2 and malignant colon neoplasm.